It is never too late to start
The addition of cannabidiol (CBD) to a routine antiepileptic drug regimen is a favorable and effective treatment option for patients with treatment‐resistant epilepsies, according to results of an interim analysis of an expanded-access program (EAP) published in Epilepsia. In the safety assessment, 607 patients were enrolled. Countable seizure types were recorded in parents’ and caregivers’ clinical
…
The addition of cannabidiol (CBD) to a routine antiepileptic drug regimen is a favorable and effective treatment option for patients with treatment‐resistant epilepsies, according to results of an interim analysis of an expanded-access program (EAP) published in Epilepsia. In the safety assessment, 607 patients were enrolled. Countable seizure types were recorded in parents’ and caregivers’ clinical
…